Please use this identifier to cite or link to this item:
Title: 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
Authors: Juan Pereyra-Rodriguez, Jose
Dominguez-Cruz, Javier
Carlos Armario-Hita, Jose
Ruiz-Villaverde, Ricardo
metadata.dc.contributor.authoraffiliation: [Juan Pereyra-Rodriguez, Jose] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain
[Dominguez-Cruz, Javier] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain
[Carlos Armario-Hita, Jose] Hosp Univ Puerto Real, Dermatol Unit, Cadiz, Spain
[Ruiz-Villaverde, Ricardo] Hosp Univ San Cecilio, Dermatol Unit, Granada, Spain
Issue Date: 9-Nov-2021
Publisher: Elsevier science inc
metadata.dc.identifier.doi: 10.1016/j.abd.2020.08.030
ISSN: 0365-0596
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons